AF
CLPT icon

Amalgamated Financial’s ClearPoint Neuro CLPT Stock Holding History

Amalgamated Financial’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$32K Buy
+3,111
New +$28.3K ﹤0.01% 2595

Other funds holding CLPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Amalgamated Financial's CLPT Position: Q1 2022 in Review

Amalgamated Financial opened a new position in ClearPoint Neuro (CLPT) in Q1 2022: 3,111 shares worth $32K. The stake represents ﹤0.01% of the portfolio and ranks #2595 among its holdings.

64 funds tracked by Wall St. Rank hold CLPT as of Q1 2022.

  • Amalgamated Financial held 3,111 shares of ClearPoint Neuro worth $32K as of Q1 2022.
  • ClearPoint Neuro was a new Amalgamated Financial position in Q1 2022.
  • ClearPoint Neuro made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2595 holding.
  • 64 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.